Disease biology in the coming decade(s).
作者信息
Rao M R S
机构信息
Jwaharlal Nehru Centre for Advanced Scientific Research, Bangalore.
出版信息
Ann Neurosci. 2012 Oct;19(4):149-50. doi: 10.5214/ans.0972.7531.190402.
Abstract
摘要
相似文献
1
Disease biology in the coming decade(s).
Ann Neurosci. 2012 Oct;19(4):149-50. doi: 10.5214/ans.0972.7531.190402.
2
Achievement of genetics in plant reproduction research: the past decade for the coming decade.
Genes Genet Syst. 2010;85(5):297-310. doi: 10.1266/ggs.85.297.
3
Bioinformatic challenges for the next decade(s).
Philos Trans R Soc Lond B Biol Sci. 2006 Mar 29;361(1467):525-7. doi: 10.1098/rstb.2005.1797.
4
Ophthalmic research prospects for the coming decade.
Am J Ophthalmol. 1979 Dec;88(6):1098-104. doi: 10.1016/0002-9394(79)90426-4.
5
Vitreoretinal disease in the coming decade.
Curr Opin Ophthalmol. 2010 May;21(3):197-202. doi: 10.1097/ICU.0b013e32833866db.
6
Defining kidney biology to understand renal disease.
Clin J Am Soc Nephrol. 2014 Apr;9(4):809-11. doi: 10.2215/CJN.10851013. Epub 2013 Dec 26.
7
The past decade--the future decade: three viewpoints. The coming of age of emergency medicine.
Emerg Med Serv. 1980 Jan-Feb;9(1):16-8.
8
Shifting patterns: merging molecules, morphogens, motility, and methodology.
Dev Cell. 2011 Jul 19;21(1):2-4. doi: 10.1016/j.devcel.2011.06.003.
9
Genetics of the long QT syndrome.
J Cardiovasc Electrophysiol. 1994 Feb;5(2):146-53. doi: 10.1111/j.1540-8167.1994.tb01155.x.
10
Congratulations on the 10-year anniversary of the National Drug Abuse Treatment Clinical Trial Network--now, what's new for the coming decade?
J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S1-3. doi: 10.1016/j.jsat.2010.02.001.
本文引用的文献
1
Identification of genomic targets of transcription factor AEBP1 and its role in survival of glioma cells.
Mol Cancer Res. 2012 Aug;10(8):1039-51. doi: 10.1158/1541-7786.MCR-11-0488. Epub 2012 Jun 20.
2
Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.
Cell. 2012 May 11;149(4):780-94. doi: 10.1016/j.cell.2012.03.031.
3
Gene pathways and subnetworks distinguish between major glioma subtypes and elucidate potential underlying biology.
J Biomed Inform. 2010 Dec;43(6):945-52. doi: 10.1016/j.jbi.2010.08.011. Epub 2010 Sep 7.
4
Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma.
Mod Pathol. 2010 Oct;23(10):1404-17. doi: 10.1038/modpathol.2010.135. Epub 2010 Aug 13.
5
Glioblastoma-specific protein interaction network identifies PP1A and CSK21 as connecting molecules between cell cycle-associated genes.
Cancer Res. 2010 Aug 15;70(16):6437-47. doi: 10.1158/0008-5472.CAN-10-0819. Epub 2010 Jul 27.
6
Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1409-22. doi: 10.1158/1055-9965.EPI-09-1077.
7
A multigene predictor of outcome in glioblastoma.
Neuro Oncol. 2010 Jan;12(1):49-57. doi: 10.1093/neuonc/nop007. Epub 2009 Oct 20.
8
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Cancer Cell. 2010 Jan 19;17(1):98-110. doi: 10.1016/j.ccr.2009.12.020.
9
Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
Nature. 2008 Oct 23;455(7216):1061-8. doi: 10.1038/nature07385. Epub 2008 Sep 4.
10
Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
Clin Cancer Res. 2008 May 15;14(10):2978-87. doi: 10.1158/1078-0432.CCR-07-4821.
Zotero 插件